Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

December 31, 2015

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Docetaxel

evaluate the activity of docetaxel on, metastatic lesions when measured after 4 cycles of chemotherapy

Trial Locations (2)

Centro Universitario Contra El Cáncer, Monterrey

Jesus Livio Jimenez Santos, Monterrey

All Listed Sponsors

lead

Centro Universitario contra el Cáncer

OTHER

NCT02041351 - Biweekly Docetaxel in Patients With Metastatic Breast Cancer. | Biotech Hunter | Biotech Hunter